Inclisiran: First Approval

Lamb, YN

Lamb, YN (corresponding author), Springer Nat, Private Bag 65901, Auckland 0754, New Zealand.

DRUGS, 2021; 81 (3): 389

Abstract

Inclisiran (Leqvio(R); Novartis) is a first-in-class, cholesterol-lowering small interfering RNA (siRNA) conjugated to triantennary N-acetylgalactosam......

Full Text Link